Skip to main content
Top
Published in: European Journal of Orthopaedic Surgery & Traumatology 5/2016

01-07-2016 | Original Article • HIP - TRAUMA

The effectiveness and safety of two prophylactic antibiotic regimes in hip-fracture surgery

Authors: Iftikhar Ahmed, M. A. Khan, V. Allgar, A. Mohsen

Published in: European Journal of Orthopaedic Surgery & Traumatology | Issue 5/2016

Login to get access

Abstract

Antibiotic prophylaxis with cefuroxime can reduce the incidence of deep wound infection (DWI) in hip-fracture surgery, but may increase the risk of C. difficile infection (CDI). An alternative is gentamicin with beta-lactam for which a question exists around clinical effectiveness and safety, given the gentamicin-associated nephrotoxicity particularly in the elderly and narrower sensitivity spectrum. We compared 744 consecutive patients (group I—cefuroxime) with 756 in group II (gentamicin + flucloxacillin) who were well matched. There were 4 cases of CDI in the cefuroxime prophylaxis, whereas none in flucloxacillin plus gentamicin (group II). There was a statistically significant (p = 0.036) increased DWI rate in group II (2.5 %) as compared to group I (1.1 %). However, after controlling for age, gender, ASA grade, surgeon grade, implant type and type of anaesthesia, there was no statistically significant difference between the two groups (p = 0.146). 8.5 % of group I and 16.5 % of group II developed AKI post-operatively (p = 0.023); however, 79 % of group I and 80 % of in group II had complete resolution of AKI prior to their discharge. Further, a significant increase in inpatient deaths (p = 0.057) in group II was observed, but not at 30 days (p = 0.378).
Literature
1.
go back to reference Marsh D et al (2007) The care of patients with fragility fractures. British Orthopaedic Association, London Marsh D et al (2007) The care of patients with fragility fractures. British Orthopaedic Association, London
2.
go back to reference White SM, Griffiths R (2011) Projected incidence of proximal femoral fracture in England: a report from the NHS Hip Fracture Anaesthesia Network (HIPFAN). Injury 42(11):1230–1233CrossRefPubMed White SM, Griffiths R (2011) Projected incidence of proximal femoral fracture in England: a report from the NHS Hip Fracture Anaesthesia Network (HIPFAN). Injury 42(11):1230–1233CrossRefPubMed
3.
go back to reference Chesser T et al (2011) The management of hip fracture in adults. National Clinical Guideline Centre, London Chesser T et al (2011) The management of hip fracture in adults. National Clinical Guideline Centre, London
4.
go back to reference Falls Free: Promoting a National Falls Prevention Action Plan: Research Review Papers (2005) NCOA Centre for Healthy Aging, pp 3–18 Falls Free: Promoting a National Falls Prevention Action Plan: Research Review Papers (2005) NCOA Centre for Healthy Aging, pp 3–18
7.
go back to reference Peel ALG, Taylor EW (1991) Proposed definitions for the audit of postoperative infection: a discussion paper. Ann RCS 73:385–388 Peel ALG, Taylor EW (1991) Proposed definitions for the audit of postoperative infection: a discussion paper. Ann RCS 73:385–388
8.
go back to reference Edwards C, Counsell A, Boulton C, Moran CG (2008) Early infection after hip fracture surgery: risk factors, costs and outcome. J Bone Joint Surg Br 90(6):770–777CrossRefPubMed Edwards C, Counsell A, Boulton C, Moran CG (2008) Early infection after hip fracture surgery: risk factors, costs and outcome. J Bone Joint Surg Br 90(6):770–777CrossRefPubMed
9.
go back to reference Chiu K, Lau S, Fung B, Ng K, Chow S (1993) Plastic adhesive drapes and wound infection after hip fracture surgery. ANZ J Surg 63:798–801CrossRef Chiu K, Lau S, Fung B, Ng K, Chow S (1993) Plastic adhesive drapes and wound infection after hip fracture surgery. ANZ J Surg 63:798–801CrossRef
10.
go back to reference Mackay DC, Harrison WJ, Bates JHJ, Dickendon D (2000) Audit of deep wound infection following hip fracture surgery. J R Coll Surg Edinb 45:56–59PubMed Mackay DC, Harrison WJ, Bates JHJ, Dickendon D (2000) Audit of deep wound infection following hip fracture surgery. J R Coll Surg Edinb 45:56–59PubMed
11.
go back to reference SIGN Guidelines no. 111“Management of hip fracture in older people”—June 2009 SIGN Guidelines no. 111“Management of hip fracture in older people”—June 2009
12.
go back to reference National Clostridium difficile Standards Group (2004) Report to the Department of Health. J Hosp Infect 56:S1–S38 National Clostridium difficile Standards Group (2004) Report to the Department of Health. J Hosp Infect 56:S1–S38
14.
go back to reference Dubberke ER, Reske KA, Yan Y et al (2007) Clostridium difficile-associated disease in a setting of endemicity: identification of novel risk factors. Clin Infect Dis 45(12):1543–1549CrossRefPubMed Dubberke ER, Reske KA, Yan Y et al (2007) Clostridium difficile-associated disease in a setting of endemicity: identification of novel risk factors. Clin Infect Dis 45(12):1543–1549CrossRefPubMed
16.
go back to reference Wilcox MH, Freeman J, Fawley W et al (2004) Long-term surveillance of cefotaxime and piperacillin-tazobactam prescribing and incidence of Clostridium difficile diarrhoea. J Antimicrob Chemother 2004(54):168–172CrossRef Wilcox MH, Freeman J, Fawley W et al (2004) Long-term surveillance of cefotaxime and piperacillin-tazobactam prescribing and incidence of Clostridium difficile diarrhoea. J Antimicrob Chemother 2004(54):168–172CrossRef
17.
go back to reference Kreisel D, Savel TG, Silver AL, Cunningham JD (1995) Surgical antibiotic prophylaxis and Clostridium difficile toxin positivity. Arch Surg 1995(130):989–993CrossRef Kreisel D, Savel TG, Silver AL, Cunningham JD (1995) Surgical antibiotic prophylaxis and Clostridium difficile toxin positivity. Arch Surg 1995(130):989–993CrossRef
18.
go back to reference Gilbert DN (2010) Aminoglycosides. In: Mandell GL, Bennett JE, Dolin R (eds) Principle and practice of infectious diseases, 7th edn. Churchill Livingstone, New York, pp 307–336 Gilbert DN (2010) Aminoglycosides. In: Mandell GL, Bennett JE, Dolin R (eds) Principle and practice of infectious diseases, 7th edn. Churchill Livingstone, New York, pp 307–336
19.
go back to reference Starks I, Ayub G, Walley G, Orendi J, Roberts P, Maffulli N (2008) Single-dose cefuroxime with gentamicin reduces Clostridium difficile-associated disease in hip-fracture patients. J Hosp Infect 70(1):21–26CrossRefPubMed Starks I, Ayub G, Walley G, Orendi J, Roberts P, Maffulli N (2008) Single-dose cefuroxime with gentamicin reduces Clostridium difficile-associated disease in hip-fracture patients. J Hosp Infect 70(1):21–26CrossRefPubMed
20.
go back to reference Katzung BG (2001) Basic & clinical pharmacology. 9th Edition, lange medical books, vol 43. McGraw Hill, New York, pp 734–764 Katzung BG (2001) Basic & clinical pharmacology. 9th Edition, lange medical books, vol 43. McGraw Hill, New York, pp 734–764
21.
go back to reference Mingeot-Leclerq MP, Tulkens PM (1999) Aminoglycosides: nephrotoxicity. Antimicrob Agents Chemother 43:1003–1012 Mingeot-Leclerq MP, Tulkens PM (1999) Aminoglycosides: nephrotoxicity. Antimicrob Agents Chemother 43:1003–1012
22.
go back to reference Rybak MJ, Abate BJ, Kang SL, Ruffing MJ, Lerner SA, Drusano GL (1999) Prospective evaluation of the effect of an aminoglycoside dosing regimen on rates of observed nephrotoxicity and ototoxicity. Antimicrob Agents Chemother 43:1549–1555PubMedPubMedCentral Rybak MJ, Abate BJ, Kang SL, Ruffing MJ, Lerner SA, Drusano GL (1999) Prospective evaluation of the effect of an aminoglycoside dosing regimen on rates of observed nephrotoxicity and ototoxicity. Antimicrob Agents Chemother 43:1549–1555PubMedPubMedCentral
23.
go back to reference Selby MN, Shaw S, Woodier N, Fluck RJ, Kolhe NV (2009) Gentamicin associated acute kidney injury. Q J Med 102:873–880CrossRef Selby MN, Shaw S, Woodier N, Fluck RJ, Kolhe NV (2009) Gentamicin associated acute kidney injury. Q J Med 102:873–880CrossRef
24.
go back to reference Patterson DL, Robson JM, Wagener MM (1998) Risk factors for toxicity in elderly patients given aminoglycosides once daily. J Gen Intern Med 13:735–739CrossRef Patterson DL, Robson JM, Wagener MM (1998) Risk factors for toxicity in elderly patients given aminoglycosides once daily. J Gen Intern Med 13:735–739CrossRef
25.
go back to reference Raveh D, Kopyt M, Hite Y, Rudensky B, Sonnenblick M, Yinnon AM (2002) Risk factors for nephrotoxicity in elderly patients receiving once-daily aminoglycosides. Q J Med 95:291–297CrossRef Raveh D, Kopyt M, Hite Y, Rudensky B, Sonnenblick M, Yinnon AM (2002) Risk factors for nephrotoxicity in elderly patients receiving once-daily aminoglycosides. Q J Med 95:291–297CrossRef
26.
go back to reference Baciewicz AM, Sokos DR, Cowan RI (2003) Aminoglycoside-associated nephrotoxicity in the elderly. Ann Pharm 37:182–186 Baciewicz AM, Sokos DR, Cowan RI (2003) Aminoglycoside-associated nephrotoxicity in the elderly. Ann Pharm 37:182–186
27.
go back to reference Levey AS et al (2005) Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 67:2089–2100 Levey AS et al (2005) Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 67:2089–2100
28.
go back to reference Craig RG, Hunter JM (2008) Recent developments in the perioperative management of adult patients with chronic kidney disease. Br J Anaes 101:296–310CrossRef Craig RG, Hunter JM (2008) Recent developments in the perioperative management of adult patients with chronic kidney disease. Br J Anaes 101:296–310CrossRef
29.
go back to reference Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG et al (2007) Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 11:R31CrossRefPubMedPubMedCentral Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG et al (2007) Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 11:R31CrossRefPubMedPubMedCentral
31.
go back to reference AlBuhairan B, Hind D, Hutchinson A (2008) Antibiotic prophylaxis for wound infections in total joint arthroplasty: a systematic review. J Bone Joint Surg Br 90:915–919CrossRefPubMed AlBuhairan B, Hind D, Hutchinson A (2008) Antibiotic prophylaxis for wound infections in total joint arthroplasty: a systematic review. J Bone Joint Surg Br 90:915–919CrossRefPubMed
33.
go back to reference Challagundla SR et al (2013) Renal impairment after high-dose flucloxacillin and single-dose gentamicin prophylaxis in patients undergoing elective hip and knee replacement. Nephrol Dial Transpl 28:612–619CrossRef Challagundla SR et al (2013) Renal impairment after high-dose flucloxacillin and single-dose gentamicin prophylaxis in patients undergoing elective hip and knee replacement. Nephrol Dial Transpl 28:612–619CrossRef
35.
go back to reference Slobogean GP, Kennedy SA, Davidson D, O’Brien PJ (2008) Single- versus multiple-dose antibiotic prophylaxis in the surgical treatment of closed fractures: a meta-analysis. J Orthop Trauma 22:264–269CrossRefPubMed Slobogean GP, Kennedy SA, Davidson D, O’Brien PJ (2008) Single- versus multiple-dose antibiotic prophylaxis in the surgical treatment of closed fractures: a meta-analysis. J Orthop Trauma 22:264–269CrossRefPubMed
36.
go back to reference Starks I et al (2008) Single-dose cefuroxime with gentamicin reduces Clostridium difficile-associated disease in hip-fracture patients. J Hosp Infect 70:21–26CrossRefPubMed Starks I et al (2008) Single-dose cefuroxime with gentamicin reduces Clostridium difficile-associated disease in hip-fracture patients. J Hosp Infect 70:21–26CrossRefPubMed
37.
go back to reference Jenkins PJ, Teoh K, Simpson PM, Dave J, Simpson AH, Breusch S (2010) Clostridium difficile in patients undergoing primary hip and knee replacement. J Bone Joint Surg Br 92:994–998CrossRefPubMed Jenkins PJ, Teoh K, Simpson PM, Dave J, Simpson AH, Breusch S (2010) Clostridium difficile in patients undergoing primary hip and knee replacement. J Bone Joint Surg Br 92:994–998CrossRefPubMed
38.
go back to reference Nicolau DP, Freeman CD, Belliveau PP, Nightingale CH, Ross JW, Quintiliani R (1995) Experience with a once-daily aminoglycoside program administered to 2,184 adult patients. Antimicrob Agents Chemother 39:650–655CrossRefPubMedPubMedCentral Nicolau DP, Freeman CD, Belliveau PP, Nightingale CH, Ross JW, Quintiliani R (1995) Experience with a once-daily aminoglycoside program administered to 2,184 adult patients. Antimicrob Agents Chemother 39:650–655CrossRefPubMedPubMedCentral
39.
go back to reference Kumin GD (1980) Clinical nephrotoxicity of tobramycin and gentamicin. A prospective study. JAMA 244:1808–1810CrossRefPubMed Kumin GD (1980) Clinical nephrotoxicity of tobramycin and gentamicin. A prospective study. JAMA 244:1808–1810CrossRefPubMed
40.
go back to reference Prins JM, Weverling GJ, de Blok K, van Ketel RJ, Speelman P (1996) Validation and nephrotoxicity of a simplified once-daily aminoglycoside dosing schedule and guidelines for monitoring therapy. Antimicrob Agents Chemother 40:2494–2499PubMedPubMedCentral Prins JM, Weverling GJ, de Blok K, van Ketel RJ, Speelman P (1996) Validation and nephrotoxicity of a simplified once-daily aminoglycoside dosing schedule and guidelines for monitoring therapy. Antimicrob Agents Chemother 40:2494–2499PubMedPubMedCentral
41.
go back to reference Munckhof WJ, Grayson ML, Turnidge JD (1996) A meta-analysis of studies on the safety and efficacy of aminoglycosides given either once daily or as divided doses. J Antimicrob Chemother 37:645–663CrossRefPubMed Munckhof WJ, Grayson ML, Turnidge JD (1996) A meta-analysis of studies on the safety and efficacy of aminoglycosides given either once daily or as divided doses. J Antimicrob Chemother 37:645–663CrossRefPubMed
42.
go back to reference Fujita K, Sayama T, Abe S, Murayama T, Tashiro H (1985) Age dependent aminoglycoside nephrotoxicity. J Urol 134:596–597PubMed Fujita K, Sayama T, Abe S, Murayama T, Tashiro H (1985) Age dependent aminoglycoside nephrotoxicity. J Urol 134:596–597PubMed
43.
go back to reference Moore RD, Smith CR, Lipski JJ, Mellits ED, Leitman PS (1984) Risk factors for nephrotoxicity in patients treated with aminoglycosides. Ann Intern Med 100:352–357CrossRefPubMed Moore RD, Smith CR, Lipski JJ, Mellits ED, Leitman PS (1984) Risk factors for nephrotoxicity in patients treated with aminoglycosides. Ann Intern Med 100:352–357CrossRefPubMed
44.
go back to reference Roche JJW, Wenn RT, Sahota O, Moran CG (2005) Effect of co-morbidities and postoperative complications on mortality after hip fracture in elderly people: prospective observational cohort study. BMJ 331:1374CrossRefPubMedPubMedCentral Roche JJW, Wenn RT, Sahota O, Moran CG (2005) Effect of co-morbidities and postoperative complications on mortality after hip fracture in elderly people: prospective observational cohort study. BMJ 331:1374CrossRefPubMedPubMedCentral
46.
go back to reference White SM, Rashid N, Chakladar A (2009) An analysis of renal dysfunction in 1511 patients with fractured neck of femur: the implications for peri-operative analgesia. Anaesthesia 64:1061–1065CrossRefPubMed White SM, Rashid N, Chakladar A (2009) An analysis of renal dysfunction in 1511 patients with fractured neck of femur: the implications for peri-operative analgesia. Anaesthesia 64:1061–1065CrossRefPubMed
Metadata
Title
The effectiveness and safety of two prophylactic antibiotic regimes in hip-fracture surgery
Authors
Iftikhar Ahmed
M. A. Khan
V. Allgar
A. Mohsen
Publication date
01-07-2016
Publisher
Springer Paris
Published in
European Journal of Orthopaedic Surgery & Traumatology / Issue 5/2016
Print ISSN: 1633-8065
Electronic ISSN: 1432-1068
DOI
https://doi.org/10.1007/s00590-016-1794-7

Other articles of this Issue 5/2016

European Journal of Orthopaedic Surgery & Traumatology 5/2016 Go to the issue

Original Article • LOWER LIMB - FRACTURES

Double locking plate fixation for femoral shaft nonunion